Dr Reddy’s says German regulator makes 6 observations on its Duvvada unit
Dr. Reddy's says a German regulator has made 6 major observations about its Duvvada drug making facility in Andhra Pradesh, sending shares down as much as 7.1%
Bengaluru/Mumbai: Dr. Reddy’s Laboratories said on Friday a German regulator has made six major observations about its Duvvada drug making facility in the southern Indian state of Andhra Pradesh, sending shares down as much as 7.1%.
Dr. Reddy’s, in an exchange filing, did not however elaborate on the observations, which typically refer to aspects of the production process that must be improved in order to gain regulatory approval for exports.
A company spokeswoman did not immediately respond to a request for details of the observations on Friday.
The products manufactured at the unit are not currently exported to the European Union, it said.
Germany and the United Kingdom contribute the most to Dr. Reddy’s revenue from Europe, which rose 28% to Rs208 crore ($32.57 million) in the June quarter. Reuters
Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
Business NewsCompaniesDr Reddy’s says German regulator makes 6 observations on its Duvvada unit
First Published:8 Sep 2017, 12:46 PM IST
- Top Gainers
- Top Losers
- 52 Week High